Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 150

Sort by

Sort Order Select

Journal Articles

Fludarabine and Melphalan Reduced Toxicity Versus a Myeloablative Fludarabine and Busulfan Conditioning Regimen for Acute Myeloid Leukemia

Vikram Mathews, Uday Kulkarni, Sushil Selvarajan, Nutan Damodar Joshi, Fouzia NA, Anu Korula, Sharon Anbumalar Lionel, Kavitha M Lakshmi, Alok Srivastava, Biju George, Aby Abraham

Blood (2023) 142 (Supplement 1): 4907.

https://doi.org/10.1182/blood-2023-188868

Published: 2023

Journal Articles

Assessment of Transduction of CD34+ Human Hematopoietic Stem Cells from Patients with Severe Hemophilia-Α with Lentiviral Vector Carrying a High Expression FVIII Transgene (CD68-ET3-LV)

Gurbind Singh, Mohanashankar A M, Shaji R Velayudhan, Gabriela Denning, Abraham Sunder Singh, Anbu Jeba, Aby Abraham, Christopher B Doering, H Trent Spencer, Alok Srivastava

Blood (2023) 142 (Supplement 1): 481.

https://doi.org/10.1182/blood-2023-188513

Published: 2023

Journal Articles

Prospective Evaluation of a Defined Replacement Protocol for Peri-Operative Hemostasis in Patients with Severe Hemophilia Α with and without Inhibitors on Emicizumab Prophylaxis Undergoing Elective Major Surgeries. (EmiSurg Study)

Blood (2023) 142 (Supplement 1): 5513.

https://doi.org/10.1182/blood-2023-184564

Published: 2023

Journal Articles

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

Molly Tokaz, Helen Baldomero, Andrew J Cowan, Wael Saber, Hildegard T. Greinix, Mickey Koh, Nicolaus Kröger, Mohamad Mohty, Sebastian Galeano, Shinichiro Okamoto, Naeem A. Chaudhri, Amado J Karduss, Fabio Ciceri, Vergilio Rensi Colturato, Selim Corbacioglu, Alaa M. Elhaddad, Lisa Force, Cristobal Augusto Frutos Ortiz, Andres Gomez-De Leon, Nada Hamad, Nelson Hamerschlak, Naya He, Aloysius YL Ho, Xiao-Jun Huang, Benjamin Jacobs, Heeje Kim, Minako Iida, Leslie E. Lehmann, Régis Peffault de Latour, Mary-Elizabeth M. Percival, Walid Rasheed, Kirk R. Schultz, Adriana Seber, Bor-Sheng Ko, Anderson Simione, Alok Srivastava, Jeff Szer, William A. Wood, Yoshihisa Kodera, Arnon Nagler, John A Snowden, Daniel J. Weisdorf, Jakob R. Passweg, Marcelo C Pasquini, Anna Sureda, Yoshiko Atsuta, Mahmoud Aljurf, Dietger Niederwieser, Martina Perdomo

Blood (2022) 140 (Supplement 1): 8146–8149.

https://doi.org/10.1182/blood-2022-158338

Published: 2022

Journal Articles

A Model-Informed Precision Busulfan Dosing in Pediatric Patients Undergoing Hematopoietic Cell Transplantation- Real-World Data

Poonkuzhali Balasubramanian, Aswin Anand PAI, Rajesh Nagarajan, Stephanie Hughes, Eunice Sindhuvi Edison, Uday Prakash Kulkarni, Aby Abraham, Alok Srivastava, Vikram Mathews, Biju George

Blood (2022) 140 (Supplement 1): 4743–4744.

https://doi.org/10.1182/blood-2022-166959

Published: 2022

Journal Articles

Fitusiran Reaches People's with Hemophilia and Their Caregivers’ Treatment Expectations: Qualitative Semi-Structured Interviews of Participants of ATLAS-OLE Trial (Interim analysis)

Alok Srivastava, Savita Rangarajan, Cecil Ross, Christina Slota, Dana DiBenedetti, Viridiana Cano, Shauna Andersson, Pronabesh Dasmahapatra, José Bartelt-Hofer, Marion Afonso

Blood (2022) 140 (Supplement 1): 7989–7990.

https://doi.org/10.1182/blood-2022-166895

Published: 2022

Journal Articles

Fitusiran, an Investigational siRNA Therapeutic Targeting Antithrombin for the Treatment of Hemophilia: First Results from a Phase 3 Study to Evaluate Efficacy and Safety in People with Hemophilia a or B without Inhibitors (ATLAS-A/B)

Alok Srivastava, Savita Rangarajan, Kaan Kavakli, Robert Klamroth, Gili Kenet, Liane Khoo, Chur-Woo You, Weiqun Xu, Niel Malan, Laurent Frenzel, Catherine N. Bagot, Oleksandra Stasyshyn, Chia-Yau Chang, Stacey Poloskey, Shauna Andersson, Zhiying Qiu, Baisong Mei, Steven W. Pipe

Blood (2021) 138 (Supplement 2): LBA-3.

https://doi.org/10.1182/blood-2021-155018

Published: 2021

Journal Articles

Efficacy and Safety of Fitusiran Prophylaxis, an siRNA Therapeutic, in a Multicenter Phase 3 Study (ATLAS-INH) in People with Hemophilia A or B, with Inhibitors (PwHI)

Guy Young, Alok Srivastava, Kaan Kavakli, Cecil Ross, Jameela Sathar, Huyen Tran, Runhui Wu, Jing Sun, Stacey Poloskey, Zhiying Qui, Salim Kichou, Shauna R. Andersson, Baisong Mei, Savita Rangarajan

Blood (2021) 138 (Supplement 1): 4.

https://doi.org/10.1182/blood-2021-150273

Published: 2021

Journal Articles

Endothelial Activation and Stress Index (EASIX) Measured Pre-Transplant Identifies a Subgroup with High Transplant Related Mortality in Patients with Thalassemia Undergoing Stem Cell Transplantation Using Thiotepa-Treosulfan-Fludarabine Conditioning

Uday Prakash Kulkarni, Aswin Anand Pai, Kavitha M Lakshmi, Sushil Selvarajan, Sharon Lionel, Anup J Devasia, Anu Korula, Fouzia NA, Eunice Sindhuvi, Aby Abraham, Alok Srivastava, Vikram Mathews, Biju George, Poonkuzhali Balasubramanian

Blood (2021) 138 (Supplement 1): 1781.

https://doi.org/10.1182/blood-2021-152153

Published: 2021

Journal Articles

Optimization of Robust Diagnostic Strategy for Patients with Fanconi Anaemia (FA)- an Indian Perspective

Gaurav Joshi, Nancy Beryl Janet, Vavish Ram, Vivek Gopalan, Thenral S G, Anurag Dutta Chaudhury, Debanjan Roy, Uday Prakash Kulkarni, Anup J Devasia, Fouzia N., Alok Srivastava, Biju George, Shaji Ramachandran Velayudhan

Blood (2021) 138 (Supplement 1): 2187.

https://doi.org/10.1182/blood-2021-153269

Published: 2021

Journal Articles

Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis

Blood (2021) 137 (4): 556–568.

https://doi.org/10.1182/blood.2020006252

Published: 2021

Includes: Supplemental data

Journal Articles

Ehl Factors at Lower Than Standard Dose Achieve Satisfactory Surgical Haemostatsis in Haemophilia

Aby Abraham, MD DM, Fouzia N., Anu Korula, MD DM, Uday Prakash Kulkarni, MD DM, Anup Devasia, MD DM, Kavitha M Lakshmi, MSc, Sandeep Albert, MS, Pradeep Poonoose, MS, Sukesh Chandran Nair, MD, Vikram Mathews, MD, Biju George, MDDM, Alok Srivastava

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-142222

Published: 2020

Journal Articles

Treosulfan Metabolite (S, S-EBDM) Pharmacokinetics Influences Regimen Related Toxicity in Patients with Beta Thalassaemia Major Undergoing HSCT

Aswin Anand PAI, MSc, John C Panetta, PhD, Ezhil Pavai Mohanan, PhD, Raveen Stephen Stallon Illangeswaran, MSc, Balaji Balakrishnan, PhD, Eunice Sindhuvi Edison, PhD, Kavitha M Lakshmi, MSc, Uday Prakash Kulkarni, MD DM, Anup Joseph Devasia, MD DM, Fouzia N., Anu Korula, MD DM, Aby Abraham, MD DM, Biju George, MDDM, Vikram Mathews, MD DM, Alok Srivastava, MD,FRACP,FRCPA, Poonkuzhali Balasubramanian, PhD

Blood (2019) 134 (Supplement_1): 1977.

https://doi.org/10.1182/blood-2019-125604

Published: 2019

Journal Articles

Impact of Graft Versus Host Disease on Outcome of Allogeneic Haematopoietic Stem Cell Transplantation for Thalassemia Major - Comparison of Bone Marrow Vs Peripheral Blood Stem Cell Grafts

Fouzia N., Uday Prakash Kulkarni, MD DM, Anup Joseph Devasia, MD DM, Anu Korula, MD DM, Kavitha M Lakshmi, MSc, Aby Abraham, MD DM, Biju George, MDDM, Vikram Mathews, MD DM, Alok Srivastava, MD,FRACP,FRCPA

Blood (2019) 134 (Supplement_1): 4537.

https://doi.org/10.1182/blood-2019-130491

Published: 2019

Journal Articles

Fludarabine and Cyclophosphamide Based Conditioning Is Associated with Good Outcomes in Patients Undergoing Matched Sibling Donor Transplants for Aplastic Anaemia

Biju George, MDDM, Aby Abraham, MD DM, Anu Korula, MD DM, Anup Devasia, MD DM, Kavitha M Lakshmi, MSc, Uday Prakash Kulkarni, MD DM, Fouzia N Abu Backer, MD DM, Alok Srivastava, MD,FRACP,FRCPA, Vikram Mathews, MD DM

Blood (2019) 134 (Supplement_1): 3272.

https://doi.org/10.1182/blood-2019-129328

Published: 2019

Journal Articles

Outcome of Immune Tolerance Induction Using an Extended Half-Life Clotting Factor Concentrate — Recombinant Factor VIII Fc (Eloctate™) — a Report from India

Aby Abraham, MD DM, Shashikant Apte, MD FRCPA, Chandrakala Shamukhaiah, MD DM, Fouzia N., DNB, DM, Kannan Subramaniam, DNB, DM, Akshata Rahate, MD DM, Abraham Sunder Singh, BSc, Aditi Joshi, BAMS, Kavitha M Lakshmi, MSc, Rajesh Phatale, MD, Shrimati Shetty, PhD, Sukesh Chandran Nair, MD, Biju George, DM, Vikram Mathews, MD, Alok Srivastava, MD, FRACP,FRCPA

Blood (2018) 132 (Supplement 1): 2494.

https://doi.org/10.1182/blood-2018-99-119279

Published: 2018

Journal Articles

Management of Relapse in Acute Promyelocytic Leukemia Treated with Upfront Arsenic Trioxide Based Regimens

Fouzia N., DNB, DM, Vibhor Sharma, MDDM, Anu Korula, MBBS, MD DM, Anup Joseph Devasia, MD DM, Uday Prakash Kulkarni, MD DM, Yasir Jeelani Samoon, MDDM, Thenmozhi Mani, PhD, Jeyaseelan Lakshmanan, PhD, Alok Srivastava, MD FRACP, FRCPA, Aby Abraham, MD DM, Poonkuzhali Balasubramanian, MSc, Biju George, DM, Vikram Mathews, MD

Blood (2018) 132 (Supplement 1): 666.

https://doi.org/10.1182/blood-2018-99-114406

Published: 2018

Journal Articles

Iron Reduction Therapy in Ex-Thalassemics - Long Term Outcome

Fouzia N., DNB, DM, Gaurav Dixit, MD DM, Kavitha M Lakshmi, MSc, Anu Korula, MD DM, Aby Abraham, MD DM, Biju George, DM, Vikram Mathews, MD, Alok Srivastava, MD

Blood (2018) 132 (Supplement 1): 4591.

https://doi.org/10.1182/blood-2018-99-116171

Published: 2018

Journal Articles

Haplo-Identical Transplants Using Post Transplant Cyclophosphamide (PTCy) Are Associated with Good Outcomes If Transplanted with Early Disease - a Single Centre Analysis from India

Biju George, DM, Aby Abraham, MD DM, Anu Korula, MD DM, Anup Joseph Devasia, MD DM, Kavitha M Lakshmi, MSc, Fouzia N., DNB, DM, Uday Prakash Kulkarni, MD DM, Alok Srivastava, MD FRACP, FRCPA, Vikram Mathews, MD

Blood (2018) 132 (Supplement 1): 4652.

https://doi.org/10.1182/blood-2018-99-118239

Published: 2018

Journal Articles

Generation of an Immortalized Erythroid Progenitor Cell Line Directly from Peripheral Blood Mononuclear Cells without Using Mobilized CD34+ Cells

Abhirup Bagchi, Aneesha Nath, MSc, Vignesh Rajendiran, M.Tech, Madhavi Maddali, MD, Ekta Jajodia, MD, Mohankumar Kumarasamypet Murugesan, MSc, PhD, Yukio Nakamura, MD PhD, Alok Srivastava, MD FRACP, FRCPA, Shaji Ramachandran Velayudhan, MSc, PhD

Blood (2018) 132 (Supplement 1): 1032.

https://doi.org/10.1182/blood-2018-99-111340

Published: 2018

NARROW

Fludarabine and Melphalan Reduced Toxicity Versus a Myeloablative Fludarabine and Busulfan Conditioning Regimen for Acute Myeloid Leukemia

Assessment of Transduction of CD34+ Human Hematopoietic Stem Cells from Patients with Severe Hemophilia-Α with Lentiviral Vector Carrying a High Expression FVIII Transgene (CD68-ET3-LV)

Prospective Evaluation of a Defined Replacement Protocol for Peri-Operative Hemostasis in Patients with Severe Hemophilia Α with and without Inhibitors on Emicizumab Prophylaxis Undergoing Elective Major Surgeries. (EmiSurg Study)

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

A Model-Informed Precision Busulfan Dosing in Pediatric Patients Undergoing Hematopoietic Cell Transplantation- Real-World Data

Fitusiran Reaches People's with Hemophilia and Their Caregivers’ Treatment Expectations: Qualitative Semi-Structured Interviews of Participants of ATLAS-OLE Trial (Interim analysis)

Fitusiran, an Investigational siRNA Therapeutic Targeting Antithrombin for the Treatment of Hemophilia: First Results from a Phase 3 Study to Evaluate Efficacy and Safety in People with Hemophilia a or B without Inhibitors (ATLAS-A/B)

Efficacy and Safety of Fitusiran Prophylaxis, an siRNA Therapeutic, in a Multicenter Phase 3 Study (ATLAS-INH) in People with Hemophilia A or B, with Inhibitors (PwHI)

Endothelial Activation and Stress Index (EASIX) Measured Pre-Transplant Identifies a Subgroup with High Transplant Related Mortality in Patients with Thalassemia Undergoing Stem Cell Transplantation Using Thiotepa-Treosulfan-Fludarabine Conditioning

Optimization of Robust Diagnostic Strategy for Patients with Fanconi Anaemia (FA)- an Indian Perspective

Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis

Ehl Factors at Lower Than Standard Dose Achieve Satisfactory Surgical Haemostatsis in Haemophilia

Treosulfan Metabolite (S, S-EBDM) Pharmacokinetics Influences Regimen Related Toxicity in Patients with Beta Thalassaemia Major Undergoing HSCT

Impact of Graft Versus Host Disease on Outcome of Allogeneic Haematopoietic Stem Cell Transplantation for Thalassemia Major - Comparison of Bone Marrow Vs Peripheral Blood Stem Cell Grafts

Fludarabine and Cyclophosphamide Based Conditioning Is Associated with Good Outcomes in Patients Undergoing Matched Sibling Donor Transplants for Aplastic Anaemia

Outcome of Immune Tolerance Induction Using an Extended Half-Life Clotting Factor Concentrate — Recombinant Factor VIII Fc (Eloctate™) — a Report from India

Management of Relapse in Acute Promyelocytic Leukemia Treated with Upfront Arsenic Trioxide Based Regimens

Iron Reduction Therapy in Ex-Thalassemics - Long Term Outcome

Haplo-Identical Transplants Using Post Transplant Cyclophosphamide (PTCy) Are Associated with Good Outcomes If Transplanted with Early Disease - a Single Centre Analysis from India

Generation of an Immortalized Erythroid Progenitor Cell Line Directly from Peripheral Blood Mononuclear Cells without Using Mobilized CD34+ Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only